The Technical Analyst
Thorne HealthTech, Inc. [THRN]
Exchange: NASDAQ Sector: Consumer Defensive Industry: Packaged Foods
Thorne HealthTech, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.10% $10.19
America/New_York / 13 okt 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 550.63 mill |
| EPS: | 0.390 |
| P/E: | 26.13 |
| Earnings Date: | Nov 09, 2023 |
| SharesOutstanding: | 54.04 mill |
| Avg Daily Volume: | 0.245 mill |
| RATING 2023-10-16 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 2.67x |
| Company: PE 26.13 | sector: PE 9.79 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.89x |
| Company: PE 26.13 | industry: PE 29.33 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.00 - 10.38 ( +/- 1.90%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-10-16 | Varma Saloni S. | Sell | 581 643 | Common Stock |
| 2023-10-16 | Mckenna Thomas P. | Sell | 1 172 227 | Common Stock |
| 2023-10-16 | Mckenna Thomas P. | Sell | 89 000 | Employee Stock Option (Right to buy) |
| 2023-10-16 | Mckenna Thomas P. | Sell | 178 000 | Employee Stock Option (Right to buy) |
| 2023-10-16 | Mckenna Thomas P. | Sell | 186 900 | Employee Stock Option (Right to buy) |
| INSIDER POWER |
|---|
| -95.82 |
| Last 93 transactions |
| Buy: 31 564 086 | Sell: 94 306 193 |
Forecast:
01:40 - $10.98
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.19 (-0.10% ) |
| Volume | 0.0847 mill |
| Avg. Vol. | 0.245 mill |
| % of Avg. Vol | 34.59 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For THRN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
THRN
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Latest Press Releases
2023-10-16 09:45:00 - Press Release
L Catterton Completes Acquisition Of Thorne Healthtech, Inc.
New york , oct. 16, 2023 /prnewswire/ -- l catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of thorne healthtech, inc. ("thorne") (nasdaq: thrn), a leader in delivering innovative solutions for a personalized approach to health and wellness. "as consumer investors, we closely follow enduring secular trends, including the consumer's increasing prioritization of health and wellness," said marc magliacano, co-managing partner of the flagship fund at l catterton.
2023-10-13 08:00:00 - Press Release
L Catterton And Thorne Healthtech, Inc. Announce Expiration Of Tender Offer
New york , oct. 13, 2023 /prnewswire/ -- l catterton and thorne healthtech, inc. ("thorne") (nasdaq: thrn) today announced that the tender offer to purchase all of the issued and outstanding shares of thorne's common stock ("shares") for $10.20 per share, net to the seller in cash, without interest and less any required withholding taxes (the "offer"), expired as scheduled at one minute past 11:59 p.m., eastern time, on october 12, 2023 and was not extended (such date and time, the "expiration time").
2023-09-27 22:47:00 - Press Release
Thorne Healthtech Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Thorne Healthtech, Inc. -thrn
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of thorne healthtech, inc. (nasdaqgs: thrn) to l catterton. under the terms of the proposed transaction, shareholders of thorne will receive $10.20 in cash for each share of thorne that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the con.
2023-08-29 21:32:00 - Press Release
Thorne Healthtech Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Thorne Healthtech, Inc. -thrn
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of thorne healthtech, inc. (nasdaqgs: thrn) to l catterton. under the terms of the proposed transaction, shareholders of thorne will receive $10.20 in cash for each share of thorne that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the con.
2023-08-28 11:28:00 - Press Release
Shareholder Alert: Ademi Llp Investigates Whether Thorne Healthtech, Inc. Has Obtained A Fair Price In Its Transaction With L Catterton
Milwaukee , aug. 28, 2023 /prnewswire/ -- ademi llp is investigating thorne (nasdaq: thrn) for possible breaches of fiduciary duty and other violations of law in its transaction with l catterton. click here to learn how to join the action https://www.ademilaw.com/case/ thorne-healthtech-inc or call guri ademi toll-free at 866-264-3995.
Latest News
2023-12-20 07:12:00 - Reuters
Thorne HealthTech taps former Vitamin Shoppe CEO Watts as leader
Private equity firm L Catterton has appointed former Vitamin Shoppe CEO Colin Watts as Thorne HealthTech's next leader following its $680 million acquisition of the U.S. health and wellness company in October.
2023-08-28 08:11:00 - Market Watch
Thorne HealthTech stock posts big gain on go-private merger with L Catterton
Thorne HealthTech Inc. stock THRN, +5.97% was up 29% in premarket trades on Monday after it said it agreed to be taken private by L Catterton for $10.20 a share in cash in a deal valued at $680 million. The price amounts to a premium of 94% over Thorne HealthTech's unaffected closing share price on July 20.
2023-08-21 12:47:12 - Zacks Investment Research
THRN vs. HQY: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Services stocks are likely familiar with Thorne Healthtech, Inc. (THRN) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
2023-08-12 12:38:02 - Seeking Alpha
Thorne HealthTech, Inc (THRN) Q2 2023 Earnings Call Transcript
Thorne HealthTech, Inc (NASDAQ:THRN ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Thomas Wilson - Vice President, Investor Relations Paul Jacobson - Chief Executive Officer Saloni Varma - Chief Financial Officer Tom McKenna - Chief Operating Officer Conference Call Participants Susan Anderson - Canaccord Genuity Patrick McNally - Evercore Operator Thank you for standing by. My name is Dina, and I will be your conference operator for today.
2023-08-01 17:15:00 - PRNewsWire
Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8
Company Withdraws Participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10 NEW YORK , Aug. 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its second quarter 2023 financial results after market close on Tuesday, Aug. 8, 2023. The company will host a conference call to discuss its results on Tuesday, Aug. 8, 2023, at 5:00 p.m.
2023-06-23 08:13:16 - InvestorPlace
3 Penny Stocks Set to Pass the $5 Mark Soon
The conventional definition of a penny stock is one that trades below $1. However, it's more common to define a penny stock as any stock that trades for less than $5.
2023-05-12 21:37:09 - Seeking Alpha
Thorne HealthTech, Inc. (THRN) Q1 2023 Earnings Call Transcript
Thorne HealthTech, Inc. (NASDAQ:THRN ) Q1 2023 Earnings Conference Call May 11, 2023 5:30 PM ET Company Participants Thomas Wilson - VP, IR Paul Jacobson - CEO Saloni Varma - CFO Tom McKenna - COO Michelle Crow - CMO Conference Call Participants Sean Dodge - RBC Elizabeth Anderson - Evercore Susan Anderson - Canaccord Steven Mah - TD Cowen Operator Good afternoon. Thank you for attending today's Thorne HealthTech, Inc. First Quarter 2020 Earnings Call.
2023-03-31 16:57:06 - Seeking Alpha
Thorne HealthTech, Inc. (THRN) Q4 2022 Earnings Call Transcript
Thorne HealthTech, Inc. (NASDAQ:THRN ) Q4 2022 Earnings Conference Call March 31, 2023 8:00 AM ET Company Participants Thomas Wilson – Vice President-Investor Relations Paul Jacobson – Chief Executive Officer Michelle Crow – Chief Medical Officer Tom McKenna – Chief Operating Officer Conference Call Participants Elizabeth Anderson – Evercore Susan Anderson – Canaccord Genuity Steven Mah – Cowen Operator Hello everyone, and welcome to the Thorne HealthTech Fourth Quarter 2022 Earnings Call. My name is Charlie and I'll be coordinating the call today.
2023-01-27 06:16:36 - Seeking Alpha
Thorne HealthTech: Strong Fundamental Potential But Cost Pressure Remains
Thorne HealthTech continues to face lower revenue growth due to macro uncertainty. Management prefers to temporarily sacrifice the gross margin, but increase brand awareness.
2022-11-11 19:38:02 - Seeking Alpha
Thorne HealthTech, Inc. (THRN) Q3 2022 Earnings Call Transcript
Thorne HealthTech, Inc. (NASDAQ:THRN ) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Thomas Wilson - Vice President, Investor Relations Paul Jacobson - Chief Executive Officer Bryan Conley - Chief Financial Officer Michelle Crow - Chief Marketing Officer Conference Call Participants Elizabeth Anderson - Evercore Sean Dodge - RBC Capital Markets Max Rakhlenko - Cowen and Co. Operator Welcome to the Thorne HealthTech Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.